Cephalexin | South Africa Drug Approvals | Medicines Control Council | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Cephalexin
South Africa

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Cephalexin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 21 USDMF, 4 JDMF, 1 EU WC, 5 NDC API, 4 Listed Suppliers, $ API Reference Price

27 API Suppliers
21 USDMF
4 JDMF
1 EU WC
5 NDC API
4 Listed Suppliers
$ API Reference Price

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 97 FDA Orange Book, 6 Europe, 6 Canada, 2 South Africa, 51 Listed Dossiers

162 FDF Dossiers
97 FDA Orange Book
6 Europe
6 Canada
2 South Africa
51 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 333MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 Rochem International Inc, 6 SPI Pharma, 12 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 1 Clariant, 7 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 26 Kerry, 1 Kima Chemical, 3 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qualicaps, 23 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 12 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 33 Direct Compression, 33 Thickeners and Stabilizers, 28 Disintegrants & Superdisintegrants, 19 Granulation, 18 Solubilizers, 17 Coating Systems & Additives, 16 Co-Processed Excipients, 16 Lubricants & Glidants, 14 Taste Masking, 13 Topical, 10 Parenteral, 10 Film Formers & Plasticizers, 9 Rheology Modifiers, 8 Empty Capsules, 8 Controlled & Modified Release, 7 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 API Stability Enhancers, 3 Coloring Agents

68 Fillers, Diluents & Binders
33 Direct Compression
33 Thickeners and Stabilizers
28 Disintegrants & Superdisintegrants
19 Granulation
18 Solubilizers
17 Coating Systems & Additives
16 Co-Processed Excipients
16 Lubricants & Glidants
14 Taste Masking
13 Topical
10 Parenteral
10 Film Formers & Plasticizers
9 Rheology Modifiers
8 Empty Capsules
8 Controlled & Modified Release
7 Emulsifying Agents
6 Chewable & Orodispersible Aids
4 Surfactant & Foaming Agents
3 API Stability Enhancers
3 Coloring Agents

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 16 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
16 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 12 Finished Drug Prices

1 US Medicaid Prescriptions
12 Finished Drug Prices

MARKET PLACE

14 APIs, 4 FDF Dossiers

14 APIs
4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 USP, 10 Others

2 USP
10 Others

$ API Ref.Price (USD/KG) : 63 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2Gulf Drug Company (Pty) Ltd

filter Active Ingredients Reset all filters

2 All

01 2Cephalexin

filter Dosage Form Reset all filters

2 All

01 1CAP

02 1FCT

filter Brand Name Reset all filters

2 All

01 1Belex 250

02 1Belex 500

List of Suppliers

Product Main Page

01

Gulf Drug Company (Pty) Ltd

Fi Europe 2024

Not Confirmed

Gulf Drug Company (Pty) Ltd

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Generic

Registration Country : South Africa

Brand Name : Belex 250

Dosage Form : FCT

Dosage Strength : 250mg

Packaging : 500X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gulf Drug Company (Pty) Ltd

Fi Europe 2024

Not Confirmed

Gulf Drug Company (Pty) Ltd

Fi Europe 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Generic

Registration Country : South Africa

Brand Name : Belex 500

Dosage Form : CAP

Dosage Strength : 500mg

Packaging : 100X1mg

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?